Compound ID | 669
Class: Peptide deformylase inhibitor
Spectrum of activity: | Gram-negative |
Details of activity: | Growth inhibitor; active against Streptococcus pneumoniae, S.aureus |
Institute where first reported: | British Biotech |
Year first mentioned: | 2000 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
Reason Dropped: | Was succeeded by the metalloenzyme inhibitors programme by Vernalis. Additionally resistance was seen (LS) |
Chemical structure(s): | |||||||||||
|
|